
LetsGo Care Editorial
Clinical 2.0 ATA Hyperbaric Oxygen Therapy vs. 1.3 ATA Mild Chambers: Evidence, Mechanisms, and Biomarkers
Clinical 2.0 ATA Hyperbaric Oxygen Therapy vs. 1.3 ATA Mild Chambers: Evidence, Mechanisms, and Biomarkers
Medical hyperbaric oxygen therapy at 2.0 ATA with intermittent 100% oxygen air breaks alters peripheral blood mononuclear cell telomere length and cerebral perfusion in small human trials, whereas mild 1.3 ATA soft…